Laura J Esserman

发表

Dedicated Breast Positron Emission Tomography for the Evaluation of Early Response to Neoadjuvant Chemotherapy in Breast Cancer

Youngho Seo, Wen Li, Bonnie N Joe, 2017, Clinical breast cancer.

Tumor-associated macrophages in breast cancer as potential biomarkers for new treatments and diagnostics

L. Esserman, M. Campbell, R. Mukhtar, 2011, Expert review of molecular diagnostics.

Consultation planning to help breast cancer patients prepare for medical consultations: effect on communication and satisfaction for patients and physicians.

Karen R. Sepucha, Karen R Sepucha, L. Esserman, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.

Zheng Zhang, Hiroyuki Abe, Thomas L Chenevert, 2018, Radiology.

The UCSC Cancer Genomics Browser

Ting Wang, David Haussler, Jingchun Zhu, 2009, Nature Methods.

Pathologic complete response predicts recurrence-free survival more effectively by cancer subset: results from the I-SPY 1 TRIAL--CALGB 150007/150012, ACRIN 6657.

Nola Hylton, Carolyn Mies, Olufunmilayo I Olopade, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.

Mariaelena Pierobon, Emanuel F Petricoin, Virginia Espina, 2008, Journal of proteome research.

Monitoring the implementation of Consultation Planning, Recording, and Summarizing in a breast care center.

Daniel F Chen, L. Esserman, J. Belkora, 2008, Patient education and counseling.

Addressing overdiagnosis and overtreatment in cancer: a prescription for change.

Sudhir Srivastava, Brian Reid, David F Ransohoff, 2014, The Lancet. Oncology.

MR spectroscopy of breast cancer for assessing early treatment response: Results from the ACRIN 6657 MRS trial

Elizabeth A Morris, Constantine A Gatsonis, Michael Garwood, 2017, Journal of magnetic resonance imaging : JMRI.

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

Anne M Wallace, Michael Hogarth, Lajos Pusztai, 2016, The New England journal of medicine.

MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.

Mitchell D Schnall, Elizabeth A Morris, Etta D Pisano, 2018, AJR. American journal of roentgenology.

Invasive breast cancer: predicting disease recurrence by using high-spatial-resolution signal enhancement ratio imaging.

Ying Lu, Ka-Loh Li, Savannah C Partridge, 2008, Radiology.

Optimized breast MRI functional tumor volume as a biomarker of recurrence‐free survival following neoadjuvant chemotherapy

John Kornak, Bonnie N Joe, L. Esserman, 2014, Journal of magnetic resonance imaging : JMRI.

Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Ying Lu, Savannah C Partridge, L. Esserman, 2002, AJR. American journal of roentgenology.

Neoadjuvant Chemotherapy for Breast Cancer: Functional Tumor Volume by MR Imaging Predicts Recurrence-free Survival-Results from the ACRIN 6657/CALGB 150007 I-SPY 1 TRIAL.

Mitchell D Schnall, Elizabeth A Morris, Constantine A Gatsonis, 2016, Radiology.

Overdiagnosis and overtreatment in cancer: an opportunity for improvement.

Brian Reid, Ian M Thompson, L. Esserman, 2013, JAMA.

The Neoadjuvant Model Is Still the Future for Drug Development in Breast Cancer

Anne Wallace, Emanuel F Petricoin, Rita Nanda, 2015, Clinical Cancer Research.